Details for Patent: 5,817,340
✉ Email this page to a colleague
Summary for Patent: 5,817,340
| Title: | Pharmaceutical compositions containing famotidine and aluminum hydroxide or magnesium hydroxide |
| Abstract: | A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a therapeutically effective amount of guanidinothiazole compound; and a therapeutically effective amount of an antacid wherein the pharmaceutical and an antacid are separated by a barrier which is substantially impermeable to an antacid. |
| Inventor(s): | Roche; Edward John (Paoli, PA), Decoteau; Susan (Mystic, CT), Freeman; Eleanor (Norristown, PA) |
| Assignee: | McNeil-PPC, Inc. (Skillman, NJ) |
| Application Number: | 08/756,080 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Dosage form; Composition; |
Drugs Protected by US Patent 5,817,340
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,817,340
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 158176 | ⤷ Try a Trial | |||
| Brazil | 1100490 | ⤷ Try a Trial | |||
| Canada | 2110313 | ⤷ Try a Trial | |||
| Germany | 69313983 | ⤷ Try a Trial | |||
| Denmark | 0600725 | ⤷ Try a Trial | |||
| European Patent Office | 0600725 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
